Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Fig. 3

Effect of aspirin on the primary prevention of individual cardiovascular disease endpoints in people with diabetes. CHD, coronary heart disease; CI, confidence interval (bars); CVD, cardiovascular disease; MI, myocardial infarction; RR, relative risk; TIA, transient ischaemic attack

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840